About UsPrescribing Practical Patent & Legal Tips for Small Pharma

Just as the right prescription can change a patient’s life, the right IP strategy can define your company’s future. We know early-stage pharma founders are juggling science, business, and relentless uncertainty. Our goal is to make patents and legal strategy accessible, actionable, and—most of all—relevant to your unique path.

IP Rx stands for:

  • Practical advice that you can use today, not just in theory.
  • Startup-focused content tailored to the realities of small teams and tight budgets.
  • Bite-sized insights—no legal jargon, no fluff.

Who Should Read IP Rx?

  • Founders and early employees at small, funded pharmaceutical and biotech startups
  • Scientists and R&D leaders who want to protect and leverage their discoveries
  • Investors and advisors supporting early-stage pharma innovation
  • Anyone navigating the intersection of groundbreaking science and commercial success

What Will You Find Here?

Our toolkit is packed with real-world solutions for common startup challenges, including:

  • Patent Fundamentals for Founders: What you need to know from your first filing to your first product.
  • Freedom to Operate: How to avoid costly roadblocks before they derail your progress.
  • Building a Lean IP Portfolio: Tips for protecting what matters most—without breaking the bank.
  • International Expansion: When, where, and why to protect your discoveries beyond the U.S.
  • Mistakes to Avoid: Learn from real-life case studies and practical checklists.
  • Expert Insights: Meet patent agents and attorneys who’ve sat on both sides of the table—science and law.

Every post is designed to give you the tools, clarity, and confidence to take your next step.

 

:

close
Loading...
Knowledge assets are defined in the study as confidential information critical to the development, performance and marketing of a company’s core business, other than personal information that would trigger notice requirements under law. For example,
The new study shows dramatic increases in threats and awareness of threats to these “crown jewels,” as well as dramatic improvements in addressing those threats by the highest performing organizations. Awareness of the risk to knowledge assets increased as more respondents acknowledged that their